EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the efficacy of Rose Bengal-PVA combinations within PCL/PLA implants for sustained cancer treatment

Sara Demartis, Camila J Picco, Eneko Larrañeta, Anna Korelidou, Rayhanul Islam, Jonathan A Coulter, Paolo Giunchedi, Ryan F Donnelly, Giovanna Rassu, Elisabetta Gavini iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01711-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Sara Demartis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, Sassari, 07100, Italy. Hauptthemen laut MEDLINE: Polyesters, Polyvinyl Alcohol, Rose Bengal, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Sassari.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current investigation aims to address the limitations of conventional cancer therapy by developing an advanced, long-term drug delivery system using biocompatible Rose Bengal (RB)-loaded polyvinyl alcohol (PVA) matrices incorporated into 3D printed polycaprolactone (PCL) and polylactic acid (PLA) implants. The anticancer drug RB’s high solubility and low lipophilicity require frequent and painful administration to the tumour site, limiting its clinical application. In this study, RB was encapsulated in a PVA (RB@PVA) matrix to overcome these challenges and achieve a localised and sustained drug release system within a biodegradable implant designed to be implanted near the tumour site. The RB@PVA matrix demonstrated an RB loading efficiency of 77.34 ± 1.53%, with complete RB release within 30 min. However, when integrated into implants, the system provided a sustained RB release of 75.84 ± 8.75% over 90 days. Cytotoxicity assays on PC-3 prostate cancer cells indicated an IC50 value of 1.19 µM for RB@PVA compared to 2.49 µM for free RB, effectively inhibiting cancer cell proliferation. This innovative drug delivery system, which incorporates a polymer matrix within an implantable device, represents a significant advancement in the sustained release of hydrosoluble drugs. It holds promise for reducing the frequency of drug administration, thereby improving patient compliance and translating experimental research into practical therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyestersPolyvinyl AlcoholRose BengalAntineoplastic AgentsProstatic NeoplasmsHumansDrug LiberationDelayed-Action PreparationsPC-3 CellsDrug Delivery SystemsCell ProliferationDrug ImplantsMaleCell Line, TumorCell SurvivalPrinting, Three-Dimensional

Stichwörter der Autor:innen

3D printingCancerImplantPolyvinyl alcoholRose BengalSustained drug release

Substanzen

PolyestersPolyvinyl AlcoholRose Bengalpoly(lactide)polycaprolactoneAntineoplastic AgentsDelayed-Action PreparationsDrug Implants

Autor:innen und Institutionen

  • Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, Sassari, 07100, Italy.
  • School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, UK.
  • School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, UK. e.larraneta@qub.ac.uk.
  • Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, 07100, Italy.
  • Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, 07100, Italy. eligav@uniss.it.

ORCID-Profile: Elisabetta Gavini

Förderung

  • Università degli Studi di Sassari

Zitieren

APA

Demartis, S., Picco, C. J., Larrañeta, E., Korelidou, A., Islam, R., Coulter, J. A., Giunchedi, P., Donnelly, R. F., Rassu, G., & Gavini, E. (2025). Evaluating the efficacy of Rose Bengal-PVA combinations within PCL/PLA implants for sustained cancer treatment. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01711-w

Vancouver

Demartis S, Picco CJ, Larrañeta E, Korelidou A, Islam R, Coulter JA, et al. Evaluating the efficacy of Rose Bengal-PVA combinations within PCL/PLA implants for sustained cancer treatment. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01711-w

BibTeX
@article{Demartis2025,
  author = {Demartis, Sara and Picco, Camila J and Larrañeta, Eneko and Korelidou, Anna and Islam, Rayhanul and Coulter, Jonathan A and Giunchedi, Paolo and Donnelly, Ryan F and Rassu, Giovanna and Gavini, Elisabetta},
  title = {Evaluating the efficacy of Rose Bengal-PVA combinations within PCL/PLA implants for sustained cancer treatment},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01711-w}
}
Kostenlos starten →